Breaking News

Rottendorf Inks Five Development and Mfg. Contracts

Employs Total Process Ownership business model

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rottendorf Pharmaceuticals has recently signed three formulation development projects and two commercial transfer projects with several top five Pharma/Biopharma companies. Additional details were not disclosed. “The new projects signed in the last quarter reflect the industry’s positive response to our business model and our commitment to Total Process Ownership (TPO),” said Rottendorf Pharmaceuticals chief executive officer, Gordon Haines. “TPO relies on open communication and exchange of ide...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters